Anti-NIPAL4 monoclonal antibody

Pre-made anti-NIPAL4 monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to NIPAL4/NIPAL4 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-IP1271-Ab-1/ GM-Tg-hg-IP1271-Ab-2Anti-Human NIPAL4 monoclonal antibodyHuman
GM-Tg-rg-IP1271-Ab-1/ GM-Tg-rg-IP1271-Ab-2Anti-Rat NIPAL4 monoclonal antibodyRat
GM-Tg-mg-IP1271-Ab-1/ GM-Tg-mg-IP1271-Ab-2Anti-Mouse NIPAL4 monoclonal antibodyMouse
GM-Tg-cynog-IP1271-Ab-1/ GM-Tg-cynog-IP1271-Ab-2Anti-Cynomolgus/ Rhesus macaque NIPAL4 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-IP1271-Ab-1/ GM-Tg-felg-IP1271-Ab-2Anti-Feline NIPAL4 monoclonal antibodyFeline
GM-Tg-cang-IP1271-Ab-1/ GM-Tg-cang-IP1271-Ab-2Anti-Canine NIPAL4 monoclonal antibodyCanine
GM-Tg-bovg-IP1271-Ab-1/ GM-Tg-bovg-IP1271-Ab-2Anti-Bovine NIPAL4 monoclonal antibodyBovine
GM-Tg-equg-IP1271-Ab-1/ GM-Tg-equg-IP1271-Ab-2Anti-Equine NIPAL4 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-IP1271-Ab-1/ GM-Tg-hg-IP1271-Ab-2; GM-Tg-rg-IP1271-Ab-1/ GM-Tg-rg-IP1271-Ab-2;
GM-Tg-mg-IP1271-Ab-1/ GM-Tg-mg-IP1271-Ab-2; GM-Tg-cynog-IP1271-Ab-1/ GM-Tg-cynog-IP1271-Ab-2;
GM-Tg-felg-IP1271-Ab-1/ GM-Tg-felg-IP1271-Ab-2; GM-Tg-cang-IP1271-Ab-1/ GM-Tg-cang-IP1271-Ab-2;
GM-Tg-bovg-IP1271-Ab-1/ GM-Tg-bovg-IP1271-Ab-2; GM-Tg-equg-IP1271-Ab-1/ GM-Tg-equg-IP1271-Ab-2
Products NameAnti-NIPAL4 monoclonal antibody
Formatmab
Target NameNIPAL4
Protein Sub-locationIntrocelluar Protein
Category of antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-NIPAL4 monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-IP1271-Ag-1Recombinant multi-species NIPA4/ NIPAL4/ ARCI6 protein
    ORF Viral VectorpGMLPm002800mouse Nipal4 Lentivirus plasmid
    ORF Viral VectorvGMLPm002800mouse Nipal4 Lentivirus particle


    Target information

    Target IDGM-IP1271
    Target NameNIPAL4
    Gene ID348938,214112,303070,715106,489157,101090487,532275,100071209
    Gene Symbol and Synonyms9530066K23Rik,ARCI6,ICHTHYIN,ICHYN,NIPA4,NIPAL4,RGD1309452,SLC57A6
    Uniprot AccessionQ0D2K0
    Uniprot Entry NameNIPA4_HUMAN
    Protein Sub-locationIntrocelluar Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000172548
    Target ClassificationN/A

    The target: NIPAL4, gene name: NIPAL4, also named as ARCI6, ICHTHYIN, ICHYN. This gene likely encodes a membrane receptor. Mutations in this gene have been associated with autosomal recessive congenital ichthyosis. [provided by RefSeq, Feb 2010].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.